Perceptive Advisors - CHINA BIOLOGIC PRODS INC ownership

Quarter-by-quarter ownership
Perceptive Advisors ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q1 2017$24,000
-4.0%
2360.0%0.00%
-50.0%
Q4 2016$25,000
-98.5%
236
-98.3%
0.00%
-98.2%
Q3 2016$1,705,000
+14.6%
13,695
-2.2%
0.11%
+6.8%
Q2 2016$1,488,000
-7.2%
14,0000.0%0.10%
-27.0%
Q1 2016$1,603,000
-90.6%
14,000
-90.5%
0.14%
-86.2%
Q2 2015$16,998,000
+154.2%
147,604
+110.9%
1.02%
+96.9%
Q1 2015$6,686,000
+34.3%
70,000
-5.4%
0.52%
+24.7%
Q4 2014$4,977,000
+3728.5%
74,023
+2984.3%
0.42%
+2878.6%
Q3 2014$130,000
+21.5%
2,4000.0%0.01%
+40.0%
Q2 2014$107,0002,4000.01%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 228,777$24,597,00012.30%
Ariose Capital Management Ltd 238,841$25,680,0008.36%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 8,400$903,0003.21%
RUDMAN ERROL M 37,001$3,978,0002.76%
INDUS CAPITAL PARTNERS, LLC 167,104$17,967,0002.33%
Ativo Capital Management LLC 90,748$9,757,0002.30%
THOMAS WHITE INTERNATIONAL LTD 130,130$13,991,0002.08%
OBERWEIS ASSET MANAGEMENT INC/ 55,855$6,006,0001.80%
Cormorant Asset Management, LP 112,867$12,135,0001.64%
BARING ASSET MANAGEMENT Ltd 143,512$15,430,0001.06%
View complete list of CHINA BIOLOGIC PRODS INC shareholders